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Abstract To analyze the regulatory mechanism of connective
tissue growth factor expression, the 3P-untranslated region (3P-
UTR) of CTGF cDNA was amplified from HeLa cell RNA.
Direct nucleotide sequencing revealed a single major population
in the amplicon, which was nearly identical to other sequences.
Subsequently, the effect of the 3P-UTR on gene expression was
evaluated. When it was fused downstream of a firefly luciferase
gene, the 3P-UTR strongly repressed luciferase gene expression.
Interestingly, the repressive effect of the antisense 3P-UTR
appeared to be more prominent than that of the sense one.
Together with the fact that several consensus sequences for
regulatory elements are found in it, these results suggest the
involvement of multiple sets of regulatory elements in the CTGF
3P-UTR.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
The connective tissue growth factor (CTGF) was initially
identi¢ed as a platelet-derived growth factor (PDGF)-related
growth factor from angioendothelial cells [1]. In early studies,
the e¡ects of CTGF on mesenchymal cells was analyzed, and
observed to be similar to PDGF [1]. Also, it had been sug-
gested that CTGF shares its receptor(s) with PDGF [1,2],
although recently, the presence of a CTGF-speci¢c receptor
on a human chondrocytic cell line HCS-2/8 has been strongly
indicated [3]. Structural similarity of CTGF and PDGF was
once implied on the basis of the cross-reactivity of an anti-
body against PDGF with CTGF, which eventually gave rise
to the identi¢cation of CTGF [1]. However, the structural
relationship between these two growth factors has been found
to be relatively distant. CTGF is a cysteine-rich secretory
protein with a molecular weight of 38 kDa, which is com-
posed of 349 amino acid residues [4]. In contrast to PDGF,
CTGF is a monomeric growth factor, and shares as much as
40% homology with PDGF at the cDNA level [1,4]. As such,
it is now widely recognized that CTGF is not an accessory
factor of PDGF, but a member of the CCN family, which
consists of ctgf (human)/¢sp12 (mouse), cef10 (chick)/cyr61
(mouse), and nov (chicken) [4^6]. Of note, the homology be-
tween ctgf and ¢sp12 is 94% at the amino acid level, suggest-
ing that CTGF is evolutionarily highly conserved, and bio-
logically indispensable in mammalian species [4].
The biological function of CTGF has been shown to be
quite diverse. Earlier studies described mitogenic and chemo-
tactic activities of CTGF on ¢broblasts, and its role(s) in
wound healing were suggested as well [5,7]. However, most
integrated functional aspects of CTGF were uncovered by our
recent research. After discovering that CTGF is preferentially
expressed in a human chondrocytic cell line, HCS-2/8 [8^13],
we have obtained sequential evidence that CTGF plays a cen-
tral role in the growth and di¡erentiation of chondrocytes
[12,14]. Namely, di¡erential expression of CTGF mRNA
was observed to follow the course of chondrocyte di¡erentia-
tion. In chondrocytes, the highest level of CTGF expression
was observed at the hypertrophic stage, whereas relatively
lower levels of expression were found in earlier stages [12].
Stimulation of proliferation and proteoglycan synthesis in
chondrocytes were also conducted by CTGF [14]. Of impor-
tance, CTGF was found to be involved in the proliferation
and migration of vascular endothelial cells [6]. Also of note,
enhancement of CTGF expression by bone morphogenetic
protein 2 (BMP-2) was observed in HCS-2/8 cells in our re-
cent study [12]. Thus, we are re-de¢ning CTGF as a major
factor to guide chondrocytes towards endochondral ossi¢ca-
tion, which may be called ‘ecogenin’.
It is widely known that, in addition to BMP-2, CTGF ex-
pression is induced by transforming growth factor L (TGF-L)
[12,15]. Save for a report which clari¢ed a novel TGF-L re-
sponsive element in the CTGF promoter [16], little has been
published about the molecular mechanism of the regulation of
CTGF gene expression. In the present study, we focused on
the 3P-untranslated region (UTR) of the human CTGF
cDNA, and evaluated its e¡ect on gene expression, utilizing
a transient assay system with COS-7 cells.
2. Materials and methods
2.1. RNA extraction and reverse transcriptase-mediated polymerase
chain reaction (RT-PCR)
Total RNA was extracted from log-phase growing HeLa cells by an
acid guanidinium phenol-chloroform method as previously described
[17]. Reverse transcription by avian myelosarcoma virus reverse tran-
scriptase was carried out using a commercially available kit (Takara
Shuzo, Tokyo, Japan) with 1.5 Wg of total RNA and a CTGF cDNA-
speci¢c oligodeoxynucleotide, CT3UTA (Fig. 1A), as an elongation
primer. Subsequent PCR ampli¢cation was also performed with the
same experimental kit, following the manufacturer’s protocol. Primers
used for ampli¢cation are illustrated in Fig. 1A: CT3UTS and CT3U-
TA, where £anking XbaI and EcoRI cutting sites are inscribed, re-
spectively. Each ampli¢cation cycle consisted of 1 min at 94‡C, 30 s at
50‡C, and 1 min at 72‡C. After 30 cycles of chain reaction and sub-
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sequent incubation at 72‡C for 5 min, PCR products were analyzed
and puri¢ed through 1.5% agarose gel electrophoresis.
2.2. Molecular clones
Prior to the construction of ¢re£y luciferase-CTGF chimeric genes,
the parental vector, pGL3-control (Promega, Madison, WI, USA) was
initially modi¢ed. A double-stranded synthetic oligonucleotide, which
confers multiple cloning sites (MCS), was synthesized, and built in
pGL3-control at the unique XbaI site immediately downstream of
the luciferase gene. Consequently, two pGL3-control derivatives
with the same MCSs in di¡erent orientations were obtained, and
designated pGL3L(+) and pGL3L(3), respectively. The major 1.0
kbp amplicon from HeLa RNA was digested with XbaI and EcoRI,
and was subcloned between the corresponding sites of pGL3L(+) or
pGL3L(3). The resultant plasmids with CTGF 3P-UTR at the end of
the ¢re£y luciferase gene were entitled pGL3UTRS or pGL3UTRA,
respectively. A negative control plasmid was also constructed from
pGL3-control. The SV40 promoter was removed from pGL3-control
by SmaI-HindIII digestion, then the HindIII overhang blunted by T4
DNA polymerase and ligase, utilizing a commercially available kit
(Takara Shuzo). The promoterless pGL3-control derivative, was
then designated as pGL3vP. The structures of these plasmids are
displayed in Fig. 2. An internal control plasmid for monitoring trans-
fection e⁄ciency was purchased and utilized. This plasmid, pRL-TK,
contains a Renilla luciferase gene under the control of the herpes
simplex virus thymidine kinase gene promoter for constitutive and
weak expression of Renilla luciferase.
2.3. Cell culture and DNA transfection
COS-7 and HeLa cells were maintained in Dulbecco’s modi¢ed
Eagle’s medium supplemented with 10% fetal bovine serum (FBS)
in humidi¢ed air with 5% CO2. Twenty hours prior to transfection,
2U105 COS-7 cells were seeded in a 35 mm tissue culture dish. Lip-
osome-mediated DNA transfection was performed with 1 Wg of each
pGL3 derivative in combination with 0.5 Wg of pRL-TK, according to
the manufacturer’s optimized methodology (LipofectAMINE: Gibco
BRL, Rockville, MD, USA). Forty-eight hours after transfection, the
cells were lysed in 500 Wl of a passive lysis bu¡er (Promega, Madison,
WI, USA). Cell lysate was directly forwarded to the luciferase assay.
2.4. Luciferase assay
The Dual Luciferase system (Promega) was applied for the sequen-
tial measurement of ¢re£y and Renilla luciferase activities with speci¢c
substrates of beetle luciferin and coelenterazine, respectively. Quanti-
¢cation of both luciferase activities and calculation of relative ratios
were carried out manually with a luminometer (TD-20/20: Turner
Designs, Sunnyvale, CA, USA).
2.5. DNA sequencing
The puri¢ed major 1 kbp PCR product of CTGF cDNA 3P-UTR
was directly subjected to automated DNA sequencing by a dye ter-
minator method (Bigdye: Applied Biosystems/Perkin Elmer, Foster
City, CA, USA). Three speci¢c primers for each DNA strand were
used therein. The nucleotide sequences of the primers other than
CT3UTS and CT3UTA (shown in Fig. 1) are:
1. CTUTS-2: 5P-CGGGATCCTCTAGACCTGTAACAAGCCAG-
AT-3P
2. CTUTA-2: 5P-GGAATTCTCGAGCACAAACAACTTTAAAT-
TAACTTAG-3P
3. CTUTS-3: 5P-CGGGATCCTCTAGAGTGCCTTTTTATTTTT-
GTTTTTAATGC-3P
4. CTUTA-3: 5P-GGAATTCTCGAGTCTGGGGAAGATAGAC-
T-3P
The nucleotide sequence of the corresponding region in pGL-3UTRS
was also obtained by the same procedure.
3. Results
3.1. Detection of CTGF mRNA in HeLa cells and isolation of
the 3P-UTR fragment
Based on a published nucleotide sequence of human CTGF
cDNA [1,12], we synthesized two CTGF-speci¢c primers for
the detection of CTGF mRNA via RT-PCR. The sense prim-
er (CT3UTS) was designed to recognize the very end of the
CTGF-coding frame, the last three nucleotides of which cor-
respond to the termination codon TGA. The antisense primer
(CT3UTA) anneals immediately upstream of the putative
poly(A) addition signal (Fig. 1A). Using these primers, we
could not only detect the expression of CTGF mRNA, but
also isolate almost the entire portion of the 3P-UTR (approxi-
mately 1.0 kbp) from CTGF cDNA. As shown in Fig. 1B, a
distinct single major band was observed on agarose gel elec-
trophoresis of the crude PCR product from HeLa RNA. The
band was excised, puri¢ed and identi¢ed as a CTGF cDNA
3P-UTR, as described in Section 3.2.
3.2. Nucleotide sequence of the CTGF 3P-UTR
The nucleotide sequence of the major amplicon, which was
determined by direct sequencing of the PCR product, revealed
its identity as the 3P-UTR portion of the CTGF cDNA. The
results of the automated sequencing by dye terminators
showed no signi¢cant variation in the major amplicon, sug-
gesting uniformity of the PCR product. The determined se-
quence was deposited into GenBank under accession number
Fig. 1. Detection of CTGF expression in HeLa cells by RT-PCR to
amplify the 3P-UTR portion of CTGF cDNA. A: Primers used for
RT-PCR and the organization of human CTGF mRNA. The rod in
the center represents a human CTGF mRNA. The small open circle
and AAAAA at the left and right end denote the 5P-cap structure
and poly-A tail, respectively. The stippled box represents the coding
region, while solid lines indicate untranslated regions. Names, loca-
tions for recognition, and nucleotide sequences of the primers used
in the PCR are given. The £anking restriction endonuclease recogni-
tion sites for cloning are also shown in each sequence. B: Agarose
gel electrophoresis analysis of the amplicon. Two microliters out of
a total reaction mixture of 100 Wl was analyzed. M: V phage DNA
HindIII digest (V-HindIII) as a chain length standard. Sizes of a few
bands in V-HindIII are shown in bp at the left of the panel. The po-
sition of the major amplicon is indicated by the arrowhead at the
right.
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AF127918. Multiple alignment with previously reported se-
quences of corresponding regions of di¡erent human origins
revealed that they are almost identical (data not shown), sug-
gesting an indispensable role for the 3P-UTR in proper CTGF
gene expression.
3.3. cis-Acting repressive e¡ect of the 3P-UTR on gene
expression
To elucidate possible e¡ects of the CTGF 3P-UTR on gene
expression, we constructed chimeric genes, in which ¢re£y
luciferase genes were fused with the RT-PCR-isolated
CTGF 3P-UTR at the 3P ends. Prior to subcloning the PCR
product, we improved the parental plasmid, pGL3-control, by
inserting a multiple cloning site at the end of the luciferase
gene, which gave rise to no signi¢cant alteration of the luci-
ferase gene expression itself (Fig. 2A: pGL3L(+) and
pGL3L(3), Fig. 2B: lanes 3 and 4). Utilizing the improved
vectors, two chimeric expression plasmids were constructed
and subjected to a calibrated transient assay with Renilla lu-
ciferase co-expression. One of the resultant plasmids, called
pGL3UTRS, contains the 3P-UTR in a sense direction of the
luciferase gene, whereas the other plasmid, pGL3UTRA, pos-
sesses the same fragment in an anti sense direction. As is clear
from Fig. 2B, both plasmids yielded strikingly low levels of
expression compared to the other three parental luciferase
expressors (i.e. 66.1% inhibition by the sense 3P-UTR;
Fig. 2. A: Structures of the plasmids used in this study. All were derived from pGL3-control (second from the top), thus the basic structure of
every plasmid is the same. Plasmids pGL3UTRS and pGL3UTRA were constructed from pGL3L(+) and pGL3L(3), respectively. Abbrevia-
tions: SVp: SV40 promoter; SVe: SV40 enhancer; poly A: SV40 polyadenylation signal; MCS: multiple cloning site; UTR: human CTGF
gene 3P-UTR fragment (the major PCR product appeared in Fig. 1B); luciferase: ¢re£y luciferase gene. B: Fire£y luciferase activity from the
plasmids displayed in A. Activity is represented as a relative value of measured luminescence from ¢re£y luciferase versus Renilla luciferase
from co-transfected pRL-TK (internal control). Mean values of the results of four experiments are displayed with error bars of standard devia-
tions except for lane 7, where the data represent the results of two experiments. Lane 1: pGL3-control. Lane 2: pGL3vP. Lane 3: pGL3L(+).
Lane 4: pGL3L(3). Lane 5: pGL3UTRS. Lane 6: pGL3UTRA. Lane 7: pGL3-control (U0.75 plasmid dose).
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80.0% inhibition by the antisense: against pGL3-control). In-
terestingly, the antisense 3P-UTR had the greatest inhibitory
e¡ect on the luciferase gene.
Since the addition of the 3P-UTR fragment also results in
an increase of the size of plasmids, it might be that chimeric
plasmids of the same weight (1 Wg) as the parental vectors
confer relatively fewer plasmid molecules for transfection,
which may a¡ect the interpretation of the results. With this
in mind, we examined luciferase gene expression from a small-
er amount of a parental plasmid, pGL3-control. Although 750
ng of pGL3-control contained fewer (90%) molecules than
1 Wg of pGL3UTRS/pGL3UTRA, it yielded luciferase activ-
ities as high as other parental plasmids, strongly indicating
that the repressive e¡ect of the CTGF 3P-UTR fragment is
striking and signi¢cant.
4. Discussion
We have detected the expression of CTGF mRNA, and
isolated the 3P-UTR cDNA fragment via RT-PCR. The ob-
served conservation of the non-coding region suggests a crit-
ical role for the corresponding region in the regulation of the
CTGF gene expression. Since the 3P-UTR of the CTGF
mRNA is unusually long (s 1000 bases), possible functional
elements are suspected particularly in this case. Indeed, our
subsequent functional analyses of the 3P-UTR have clearly
uncovered its remarkable repressive e¡ects on gene expres-
sion. Since the e¡ects have been evaluated under saturated
levels of basal transcription (i.e. 750 ng and 1 Wg of pGL3-
control gave rise to a minimal di¡erence in results), the re-
pressive e¡ects of the 3P-UTR seem to be quite distinct and
e⁄cient against active gene expression.
From our results, it is clear that negative regulatory ele-
ments exist in the CTGF 3P-UTR. Since there have been a
number of studies on cis-acting negative regulatory elements
such as silencers and RNA destabilizers, we also sought pos-
sible candidates for such elements. As a consequence, several
sequences that are identical or highly homologous to known
negative regulatory cis elements were identi¢ed, which are
summarized in Fig. 3. Three AT-rich elements to destabilize
mRNA [18,19] and three silencer elements found in tumor
necrosis factor receptor [20], all of which perfectly match
the originals, were present in the corresponding area. Two
other silencer-like elements can be speci¢ed as well. One
near the 5P-end of the sense strand retains 90.9% homology
to the silencer element of rat CYP1A1 gene [21,22], and the
other, a 26 bp element in the middle, shares 65.4% homology
with the YY1-binding silencer of the human interferon-Q gene
[21,23]. Needless to say, they are potential candidates for the
functional repressive elements built in the 3P-UTR. However,
in addition, an orientation-dependent positive regulatory ele-
ment may be present, since the antisense 3P-UTR construct
conferred a more pronounced repressive e¡ect than the sense
construct. Of note, it is widely recognized that the 3P-UTR of
a gene is an appropriate location for mRNA export signals
[24,25].
CTGF is a multi-functional growth factor that potentiates
either growth or di¡erentiation of various types of mesenchy-
mal cells, according to biological conditions [1,5^7,14]. More-
over, gene expression of CTGF in vivo is normally low but is
induced during cytodi¡erentiation or in pathological states
[5^7,12]. For example, CTGF expression in growth cartilage
cells increased as the cells di¡erentiated to the hypertrophic
stage [12]. The mechanism of this controlled expression of
CTGF in chondrocytes is as yet unclear. Nevertheless, it is
highly likely that the regulatory function of the 3P-UTR,
which has been uncovered by our present work, is involved
in this di¡erential regulation of CTGF expression, as a strictly
tuned system may require multiple regulatory factors. In-
vestigation of the 3P-UTR function in chondrocytic cells
may shed light on critical aspects of the regulatory mechanism
of gene expression.
In summary, the CTGF 3P-UTR is quite long and con-
served, hence involvement of multiple regulatory elements,
including positive e¡ectors, is expected, which may be one
of the major parts of the regulation machinery enabling the
di¡erential expression of the CTGF gene. Further functional
dissection of the 3P-LTR is currently under way.
Acknowledgements: This work was supported in part by Grants-in-
Aid for Scienti¢c Research from the Ministry of Education, Science,
Sports and Culture of Japan (T.N., M.T.) and grants from the Naito
Foundation (M.T.), the Nakatomi Health Science Foundation (M.T.)
and the Foundation for Growth Science in Japan (M.T.). The authors
wish to thank Drs. Takashi Nishida, Takuo Fujisawa, Masahiro Asa-
no and Gen Yoshimichi for helpful suggestions, Ms. Masako Hata for
technical assistance, and Ms. Etsuko Fujisawa for secretarial assist-
ance.
Fig. 3. Putative cis-acting negative regulatory elements in the CTGF
3P-UTR. The entire nucleotide sequence (except primers) of the
subcloned 3P-UTR fragment in pGL3UTRS is displayed. Only one
base was found to be di¡erent from the direct sequencing results of
PCR product, which is underlined here. Putative RNA destabilizing
elements are marked by open boxes, whereas putative silencer ele-
ments are indicated by stippled boxes. Arrows pointing upstream
denote the elements with consensus sequences in the antisense
strand.
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